Percutaneous coronary intervention (PCI) and minimally invasive direct coronary artery bypass (MIDCAB) grafting are both established therapeutic options for single-vessel disease of the left anterior descending artery (LAD). The present systematic review with meta-analysis aims to determine the current strength of evidence for or against PCI and MIDCAB for revascularization of the LAD. Therefore, we performed a meta-analysis of randomized, controlled trials (RCTs) and observational trials (OTs) that reported clinical outcome after isolated LAD revascularization. Analysed postoperative outcomes included major adverse cardiac and cerebrovascular events (MACCEs), all-cause mortality, myocardial infarction and stroke. Pooled treatment effects [odds ratio (OR) or weighted mean difference (WMD), 95

作者：Antje-Christin, Deppe；Oliver J, Liakopoulos；Elmar W, Kuhn；Ingo, Slottosch；Maximilian, Scherner；Yeong-Hoon, Choi；Parwis B, Rahmanian；Thorsten, Wahlers

来源：European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2015 年 47卷 3期